Clinical Trial Update: Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating biomarker-guided fluorouracil in colorectal cancer patients receiving combination chemotherapy. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Colorectal Cancer, Diarrhea | Phase 1 | Status: COMPLETED